Release Date: 27/07/09 11:34 Summary: June Quarter 2009 Activities and Cashflow Report Price Sensitive: Yes Download Document 491.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%